PER 2.70% 7.6¢ percheron therapeutics limited

Ann: Dosing commenced in the ATL1102 toxicology study, page-7

  1. 2,956 Posts.
    lightbulb Created with Sketch. 116
    Whilst ANP maintains the current management structure (CEO) and no funding pathways this one is going anywhere.

    Current news coming out of ANP has been fantastic, however these 2 aspects imo has the market and big investors sitting back watching and waiting.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.002(2.70%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.5¢ 7.6¢ 7.5¢ $29.46K 393.5K

Buyers (Bids)

No. Vol. Price($)
1 7453 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 15846 3
View Market Depth
Last trade - 11.48am 07/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.